<h1>Auro Impex and Chemicals Limited Approves Increase in Authorized Share Capital</h1>
The Board of Directors of Auro Impex & Chemicals Limited has approved a significant increase in the company's Authorized Share Capital and subsequently altered the Memorandum of Association during its meeting held on August 8, 2026. The decisions cover the capital structure, as well as preparatory steps for the upcoming Annual General Meeting (AGM).
The company modified Clause V of its Memorandum of Association to reflect the updated share capital details. Under the alteration, the Authorized Share Capital of Auro Impex & Chemicals Limited was set at Rs. 20,00,00,000/- (Rupees Twenty crore). This capital is structured into 2,00,00,000 (Two Crore) equity shares, each valued at Rs.10/-(Rupees ten only).
The details of the authorized share capital and its structure are as follows:
| Financial Detail | Specification |
|---|---|
| Authorized Share Capital | Rs. 20,00,00,000/- (Rupees Twenty crore) |
| Number of Equity Shares | 2,00,00,000 (Two Crore) |
| Face Value per Share | Rs. 10/- (Rupees ten only) |
In addition to the capital structure changes, the board meeting approved the notice for the company's 33rd Annual General Meeting (AGM). The AGM is scheduled to take place on September 12, 2026. To ensure smooth corporate governance processes ahead of the AGM, a cut-off date of September 5, 2026, has been fixed for remote e-voting. This deadline will ascertain the names of shareholders—whether holding shares in physical or dematerialized form—who are entitled to cast their votes electronically concerning the business items scheduled for the AGM.
AUROIMPEX Stock Price Movement
Auro Impex & Chemicals Limited's equity settled flat today, closing at ₹26.50 after the market session finished. The share price maintained stability throughout trading, reflecting zero change as the company wrapped up the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.